2 studies found for:    10984541 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study
Conditions: Infant, Premature;   Erythropoietin;   Brain Injury;   Intraventricular Hemorrhage;   Periventricular Leukomalacia;   Neurodevelopmental Outcomes;   Randomized Clinical Trial
Interventions: Drug: Erythropoietin;   Drug: Saline placebo
2 Unknown  Can Erythropoietin Protect the Cerebral Blood Flow and Oxygenation During Simulated Dive?
Condition: Healthy
Intervention: Drug: Recombinant human Erythropoietin

Indicates status has not been verified in more than two years